Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade-Reference-Cited by-同舟云学术

Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade

Published:2017-01 Issue: Volume:136 Page:49-55
ISSN:0167-5877
Container-title:Preventive Veterinary Medicine
language:en
Short-container-title:Preventive Veterinary Medicine

Author:

Spedicato Massimo,Lorusso Alessio,Salini Romolo,Gennaro Annapia Di,Leone Alessandra,Teodori Liana,Casaccia Claudia,Portanti Ottavio,Calistri Paolo,Giovannini Armando,Savini Giovanni

Funder

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Animal Science and Zoology,Food Animals

Reference37 articles.

1. Eradication of bluetongue disease in Germany by vaccination;Baetza;Vet. Immunol. Immunopathol.,2014

2. Inactivated bluetongue virus vaccine in lambs: differential serological responses related to breed;Berry;Vet. Res. Commun.,1982

3. Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats;Bréard;Vaccine,2011

4. Complete genome sequence of bluetongue virus serotype 8, which reemerged in France in august 2015;Bréard;Genome Announc.,2016

5. Antibody response in cattle vaccinated against Bluetongue serotype 8 in Italy;Calistri;Transbound. Emerg. Dis.,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8;Vaccine;2019-09

2. Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR −/− mice;Vaccine: X;2019-08

3. Molecular typing of Bluetongue virus using the nCounter® analysis system platform;Journal of Virological Methods;2019-07

4. Bluetongue virus vaccine: conventional to modern approach;Acta virologica;2019

5. Effectiveness and cost‐benefit study to encourage herd owners in a cost sharing vaccination programme against bluetongue serotype‐8 in Belgium;Transboundary and Emerging Diseases;2018-10-26